Atlas Trials

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Clinical trial NCT04889287 · COMPLETED

Trial details

NCT number
NCT04889287
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Start date
2021-05-26
Primary completion
2021-07-23
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.